POSTER SESSION IV Tuesday, February 14, 2006   —  1:00 - 4:30 PM Exhibit Level GYNECOLOGIC PATHOLOGY 101 The Presence of Endosalpingiosis and Proliferative Endosalpingiosis May Predict a Higher Risk of Recurrence in Ovarian Borderline Tumors: A Clinicopathologic Study of 254 Cases (895) MR Quddus, CJ Sung, MM Steinhoff, C Zhang, F Liu, R Moore, WD Lawrence - Women & Infants Hospital, Brown Medical School, Providence, RI 102 Does Micropapillarity in Ovarian Serous Borderline Tumors Represent a Transition Between Typical Ovarian Serous Borderline Tumors and Low Grade Serous Carcinoma? Finding Answers Using the Level of Selenium-Binding Protein Expression in 64 Ovarian Tumors (943) C Zhang, YE Wang, P Zhang, F Liu, CJ Sung, MR Quddus, MM Steinhoff, WD Lawrence - Women & Infants Hospital of Rhode Island, Providence, RI 103 Nuclear Size Distinguishes Low- From High-Grade Ovarian Serous Carcinoma And Predicts Outcome (839) CY Hsu, RJ Kurman, R Vang, TL Wang, J Baak, IM Shih - Taipei Veterans General Hospital, National Yang-Ming University School of Medicine, Taipei, Taiwan; Johns Hopkins Medical Institutions, Baltimore, MD; Central Hospital in Rogaland, Stavanger, Norway 104 Rsf-1 Is Significantly Expresssed In High Grade Ovarian Serous Carcinoma (873) TL Mao, RJ Kurman, TL Wang, IM Shih - The Johns Hopkins University School of Medicine, Baltimore, MD 105 Expression of Poly(ADP-ribose) Polymerase (PARP) in Ovarian Serous Carcinoma (800) H Brustmann - Thermenklinikum Moedling, Moedling/Vienna, Lower Austria, Austria 106 Expression Of Hypoxia-Related Markers, GLUT-1 And HIF-1alpha, In The Ovarian Tumors: Association With Histology And Tumor Grade (939) M Yasuda, M Miyazawa, T Minematsu, K Hirabayashi, H Kajiwara, T Iida, YR Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan 107 Hepsin Expression In Surface Epithelial Carcinomas Of The Ovary. An Immunohistochemical Tissue Microarray Analysis Of 70 Cases (870) E Lopez-Varela, AF Fuller, S Orsulic, J Miao, KU Parks, E Oliva - Massachusetts General Hospital, Boston, MA 108 Expression Profile of Novel Membrane Progesterone Receptors in Epithelial Ovarian Tumors (903) M Romero-Sanchez, S Peiper, B Evans, Z Wang, A Ribe, Ll Catasus, J Prat, J Giri - Medical College of Georgia, Augusta, GA; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain 109 Potential Predictors Of Chemotherapy Response In Ovarian Cancer - How Do We Define Chemosensitivity? (882) SA O'Toole, A Laios, BL Sheppard, NC Gleeson, T D'Arcy, EPJ McGuinness, J Bonnar, O Sheils, JJ O'Leary - Trinity College Dublin, Dublin, Ireland 110 Histopathologic Criteria For Assessment Of Treatment Response And Tumor Regression In Advanced Ovarian Cancer After Neoadjuvant Chemotherapy (905) S Sassen, F Fend, W Kuhn, N Avril, B Schmalfeldt, R Busch, H Hoefler, J Naehrig - Technical University Munich, Munich, Germany; University of Bonn, Bonn, Germany 111 Gene Expression Profiles of Ovarian Serous Carcinoma After Neoadjuvant Chemotherapy (907) PA Shaw, M Agochiya, M Sharma, J Murphy, B Rosen, TJ Brown, H Begley, I Jurisica - University of Toronto, Toronto, ON, Canada 112 DNA Methylation of Tumor Suppressor Genes Associates with Chemoresistance and Early Recurrence in Patients with Ovarian Serous Carcinoma (944) X Zhang, L Wang, A Green, B Yang - Cleveland Clinic Foundation, Cleveland, OH 113 Discrete and Intense p53 Immunostaining in Morphologically Normal Fallopian Tube Epithelium: Frequency, Cell Phenotypes and Comparison to Serous Carcinoma (861) Y Lee, F Medeiros, FD McKeon, MG Muto, D Cramer, CP Crum - Brigham and Women's Hospital, Harvard Medical School, Boston, MA 114 Adenofibroma of the Fallopian Tube: A Common Neoplasm Arising from the Fimbria. (797) V Bossuyt, F Medeiros, CP Crum - Brigham and Women's Hospital, Boston, MA 115 Brenner Tumors But Not Transitional Cell Carcinomas Of The Ovary Show Dysregulation Of Cell Cycle G1-S Phase Transition (900) A Ribe, CV Larrosa, Ll Catasus, J Palacios, J Prat - Hospital de Sant Pau, Autonomous University, Barcelona, Spain 116 Expression of D2-40 in Primary Peritoneal Serous Carcinomas, Ovarian Serous Carcinomas, Uterine Carcinomas and Sex Cord Stromal Tumors. (807) M Chivukula, M Kapali - Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA 117 Diagnostic Limitation of D2-40 in Separating Ovarian Serous Carcinoma From other Metastatic Carcinoma of the Abdomen (846) DL Jones, KL Denning, RS Saad, YL Liu, X Lin, M Tung, JF Silverman - Allegheny General Hospital, Pittsburgh, PA 118 D2-40 Expression in Ovarian and Endometrial Adenocarcinomas: A Tissue Microarray Study (912) AE Sienko, D Coffey, NA Singhal, L Garza - The Methodist Hospital, Houston, TX 119 Immunohistochemical Expression of p16 and p53 in Uterine Serous Carcinoma and High-Grade Ovarian Serous Carcinoma (806) AG Chiesa, A Malpica, MT Deavers, RR Broaddus, EG Silva - MD Anderson Cancer Center, Houston, TX 120 WT-1 Expression in Tissue Microarray (TMA) of 50 Ovarian Carcinomas and 59 Primary Uterine Adenocarcinomas (913) AE Sienko, D Coffey, NA Singhal, L Garza - The Methodist Hospital, Houston, TX 121 Comparison of Immunohistochemical Expression of MUC1, MUC2, MUC4, MUC5AC and MUC6 in Ovarian Mucinous Adenomas, Borderline Tumors and Adenocarcinomas (837) K Hirabayashi, H Kajiwara, M Yasuda, YR Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan 122 Metastatic Colorectal Adenocarcinoma with Ovarian Involvement and Elevated Serum CA125: A Potential Diagnostic Pitfall (864) MR Lewis, ED Euscher, MT Deavers, EG Silva, A Malpica - U of Vermont, Burlington, VT; UT MD Anderson Cancer Center, Houston, TX 123 VILLIN Expression Does Not Distinguish Primary Mucinous Ovarian Tumors From Metastatic Mucinous Tumors of the Ovary (831) K Garg, LW Browne, CJ Zaloudek, JT Rabban - University of California, San Francisco, San Francisco, CA 124 Expression Of CK7 And CK20 In Ovarian Mucinous Tumors Arising In Association With Teratomas: A CK7-/CK20+ Subset Can Cause Confusion With Metastatic Lower Gastrointestinal (GI) Tract Mucinous Tumors (927) R Vang, AM Gown, C Zhao, TS Barry, BM Ronnett - The Johns Hopkins Hospital, Baltimore, MD; PhenoPath Laboratories, Seattle, WA; AFIP, Washington, DC 125 Ovarian Metastases of Appendiceal Tumors with Goblet Cell Carcinoid-Like Features: Limited Expression of Neuroendocrine Markers and Clinicopathologic Features of Aggressive Invasive Carcinoma Support Designation as Adenocarcinoma Rather Than Goblet Cell Carcinoid Tumor (838) AC Hristov, R Vang, RH Young, JD Seidman, BM Ronnett - The Johns Hopkins Hospital, Baltimore, MD; Massachusetts General Hospital, Boston, MA; Washington Hospital Center, Washington, DC 126 Ovarian Non-Small Cell Neuroendocrine Carcinoma: A Clinicopathologic and Immunohistochemical Study of 11 Cases (929) E Veras, EG Silva, MT Deavers, A Malpica - UT-Houston Medical School, MD Anderson Cancer Center, Houston, TX 127 Small Cell Carcinoma of the Ovary of the Hypercalcemic Type: A Highly Aggressive Neoplasm Without CGH Aberrations (836) S Hauptmann, H Schmidt, U Bilkenroth, M Köbel, B Czernobilsky, L Roth, G McCluggage, RE Scully, E Oliva - Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany; Patho-Lab Ltd, Nes-Ziona, Israel; Indiana University Medical Center, Indianapolis, IN; Royal Group of Hospital Trusts, Belfast, North-Ireland, United Kingdom; Massachusetts General Hospital, Boston, MA 128 Comparative Analysis of Alternate Immunohistochemical (IHC) Markers for the Distinction of Ovarian Sertoli Cell Tumors from Endometrioid Tumors and Carcinoid Tumors: A Study of 160 Cases (947) C Zhao, R Vang, GL Bratthauer, R Barner - Armed Forces Institute of Pathology, Washington, DC; LAC+USC Medical Center, Los Angeles, CA; Johns Hopkins Hospital, Baltimore, MD 129 Comparative Immunohistochemical Analysis Of ER/PR Expression In Ovarian Sertoli Cell Tumors (SCT) And Adult Granulosa Cell Tumors (AGCT) (821) MA Farinola, AM Gown, TS Barry, S Movahedi-Lankarani, R Vang - The Johns Hopkins Hospital, Baltimore, MD; PhenoPath Laboratories, Seattle, WA 130 Molecular Genetic Evidence Supporting the Neoplastic Nature of the Leydig Cell Component of Ovarian Sertoli-Leydig Cell Tumor (817) RE Emerson, M Wang, LM Roth, W Zheng, FW Abdul-Karim, F Liu, TM Ulbright, JN Eble, L Cheng - Indiana University School of Medicine, Indianapolis, IN; Yale University, New Haven, CT; Case Western Reserve University, Cleveland, OH; Women & Infants Hospital and Brown Medical School, Providence, RI 131 Chromosome 12p Abnormalities in Dysgerminoma of the Ovary and Its Biological and Diagnostic Implications (809) P Cossu-Rocca, S Zhang, LM Roth, JN Eble, W Zheng, FW Abdul Karim, H Michael, RE Emerson, TD Jones, EM Hattab, L Cheng - Indiana University, Indianapolis, IN; Universita di Sassari, Sassari, Italy; Yale University, New Haven, CT; Case Western Reserve University, Cleveland, OH 132 Molecular Analysis of Bilateral Mature Cystic Ovarian Teratoma (902) AG Rivenbark, BK Buckley, KK White, WB Coleman, DB Thomas - University of North Carolina School of Medicine, Chapel Hill, NC 133 Paraganglioma Of The Ovary: Three Cases Of An Extremely Rare Primary Ovarian Neoplasm, Including Two Exhibiting Inhibin Positivity (875) WG McCluggage, RH Young - Royal Group of Hospitals Trust, Belfast, United Kingdom; Massachusetts General Hospital, Boston, MA 134 Extra-Axial Ependymomas Are Distinct From Central Nervous System Ependymomas (917) RA Soslow, XJ Wei, K Park, M Rosenblum, J Woodruff, M Edgar - Memorial Sloan-Kettering Cancer Center, New York, NY